MEI Pharma, Inc. MEIP
Set alert
3.07 USD 0.00 0.00%
At close · Sep 10
2.85 Day range 3.25
2.30 52-week range 6.39
- YTD
- +132.58%
- 1 year
- +132.58%
- Open
- 2.89
- Prev close
- 3.07
- Mkt cap
- 15.72M
- Vol
- 3.97M
- Avg vol
- 46.70K
- EPS
- -6.99
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.85
- High
- 3.25
- Forward P/E
- -0.64
- Beta
- 0.71
- Short ratio
- 0.94
- Inst. own
- 41.04%
- Dividend
- 0.00
- Ex-div date
- Nov 15, 2023
- Earnings
- Feb 11, 2025
- 50-d avg
- 2.83
- 200-d avg
- 3.10
- 1y target
- 0.00
Analyst view
Consensus: none
Price target (mean) 0.00
Ratings (0m) 2 0 buy · 2 hold · 0 sell
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -1.66 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | -100.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 23, 2024 | Laidlaw & Co. | Downgrade | Buy | Hold |
| Apr 12, 2024 | Stifel | Maintained | Hold | Hold |
| Feb 14, 2024 | Stifel | Maintained | Hold | Hold |
| Sep 27, 2023 | Stifel | Maintained | Hold | Hold |
| May 23, 2023 | Brookline Capital | Maintained | Buy | Buy |
| May 12, 2023 | Stifel | Maintained | Hold | Hold |